• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻 HER2 阳性转移性乳腺癌患者的妊娠——在复发恐惧与生育愿望之间。

Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate.

机构信息

ANAPATMOL Research Center, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.

Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania.

出版信息

Curr Oncol. 2023 May 8;30(5):4833-4843. doi: 10.3390/curroncol30050364.

DOI:10.3390/curroncol30050364
PMID:37232822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10217573/
Abstract

Breast cancer is the most frequent neoplasm among women and the second leading cause of death by cancer. It is the most frequent cancer diagnosed during pregnancy. Pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy and/or in the postpartum period. Data about young women with metastatic HER2-positive cancer who desire a pregnancy are scarce. The medical attitude in these clinical situations is difficult and nonstandardized. We present the case of a 31-year-old premenopausal woman diagnosed in December 2016 with a stage IV Luminal HER2-positive metastatic breast cancer (pT2 N0 M1 hep). The patient was initially treated by surgery in a conservative manner. Postoperatively, the presence of liver metastases was found by CT investigation. Consequently, line I treatment (docetaxel l75 mg/m² iv; trastuzumab 600 mg/5 mL sq) and ovarian drug suppression (Goserelin 3.6 mg sq at 28 days) was administered. After nine cycles of treatment, the patient's liver metastases had a partial response to the therapy. Despite having a favorable disease evolution and a strong desire to procreate, the patient vehemently refused to continue any oncological treatment. The psychiatric consult highlighted an anxious and depressive reaction for which individual and couple psychotherapy sessions were recommended. After 10 months from the interruption of the oncological treatment, the patient appeared with an evolving pregnancy of 15 weeks. An abdominal ultrasound revealed the presence of multiple liver metastases. Knowing all the possible effects, the patient consciously decided to postpone the proposed second-line treatment. In August 2018, the patient was admitted in the emergency department with malaise, diffuse abdominal pain and hepatic failure. Abdominal ultrasound found a 21-week-old pregnancy which had stopped in evolution, multiple liver metastases and ascites in large quantity. She was transferred to the ICU department where she perished just a few hours later. Conclusions/Discussion: From a psychological standpoint, the patient had an emotional hardship to make the transition from the status of a healthy person to the status of a sick person. Consequently, she entered a process of emotional protection of the positive cognitive distortion type, which favored the decision to abandon treatment and try to complete the pregnancy to the detriment of her own survival. The patient delayed the initiation of oncological treatment in pregnancy until it was too late. The consequence of this delay in treatment led to the death of the mother and fetus. A multidisciplinary team worked to provide this patient with the best medical care and psychological assistance throughout the course of the disease.

摘要

乳腺癌是女性最常见的肿瘤,也是癌症死亡的第二大主要原因。它是怀孕期间最常见的诊断出的癌症。与妊娠相关的乳腺癌是指在妊娠期间和/或产后诊断出的乳腺癌。关于希望怀孕的年轻女性转移性 HER2 阳性癌症的数据很少。在这些临床情况下,医疗态度是困难且不标准的。我们介绍了一位 31 岁的绝经前妇女的病例,她于 2016 年 12 月被诊断为四期 Luminal HER2 阳性转移性乳腺癌(pT2 N0 M1 hep)。该患者最初通过手术进行了保守治疗。术后通过 CT 检查发现存在肝转移。因此,给予一线治疗(多西他赛 l75 mg/m² iv;曲妥珠单抗 600 mg/5 mL sq)和卵巢药物抑制(戈舍瑞林 3.6 mg sq 每 28 天)。在进行了九个周期的治疗后,患者的肝转移对治疗有部分反应。尽管疾病进展良好,并且强烈希望生育,但患者强烈拒绝继续任何肿瘤治疗。精神科咨询突出了焦虑和抑郁反应,建议进行个体和夫妻心理治疗。在中断肿瘤治疗 10 个月后,患者出现了 15 周的妊娠。腹部超声显示存在多个肝转移。患者了解所有可能的影响后,有意识地决定推迟拟议的二线治疗。2018 年 8 月,患者因不适、弥漫性腹痛和肝功能衰竭到急诊就诊。腹部超声发现 21 周的妊娠停止发育,多个肝转移和大量腹水。她被转至 ICU 病房,几个小时后去世。结论/讨论:从心理角度来看,患者在从健康人过渡到病人的过程中感到困难。因此,她进入了一种情绪保护的过程,即积极认知扭曲型,这有利于放弃治疗并尝试完成妊娠的决定,而不顾自身的生存。患者在怀孕期间推迟了开始肿瘤治疗的时间,直到为时已晚。这种治疗延迟的后果导致母亲和胎儿死亡。一个多学科团队努力为患者提供最佳的医疗护理和心理援助,贯穿整个疾病过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/da6bc13c00b4/curroncol-30-00364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/927fbccc3ee0/curroncol-30-00364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/d22e388f9635/curroncol-30-00364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/561b98574ee7/curroncol-30-00364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/da6bc13c00b4/curroncol-30-00364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/927fbccc3ee0/curroncol-30-00364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/d22e388f9635/curroncol-30-00364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/561b98574ee7/curroncol-30-00364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/854b/10217573/da6bc13c00b4/curroncol-30-00364-g004.jpg

相似文献

1
Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate.年轻 HER2 阳性转移性乳腺癌患者的妊娠——在复发恐惧与生育愿望之间。
Curr Oncol. 2023 May 8;30(5):4833-4843. doi: 10.3390/curroncol30050364.
2
Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female: A case report.年轻妊娠女性晚期HER2阳性乳腺癌的诊断与治疗:一例报告
Medicine (Baltimore). 2020 Oct 30;99(44):e22929. doi: 10.1097/MD.0000000000022929.
3
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
4
Management of HER2-Positive Breast Cancer for a Young Patient with Visceral Crisis-The Adjuvant Role of Lifestyle Changes.年轻伴有内脏危象的 HER2 阳性乳腺癌患者的管理-生活方式改变的辅助作用。
Curr Oncol. 2022 Mar 10;29(3):1890-1901. doi: 10.3390/curroncol29030154.
5
Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.人表皮生长因子受体 2 阳性转移性乳腺癌伴新型表皮生长因子受体-ZNF880 融合和表皮生长因子受体 E114K 突变,吡咯替尼治疗有效:一例报告。
Medicine (Baltimore). 2020 Dec 18;99(51):e23406. doi: 10.1097/MD.0000000000023406.
6
[Two Cases of Unresectable/Advanced Breast Cancer with Pathological Complete Response after Combination Chemotherapy with Pertuzumab. Trastuzumab, and Docetaxel].[两例不可切除/晚期乳腺癌经帕妥珠单抗、曲妥珠单抗和多西他赛联合化疗后达到病理完全缓解]
Gan To Kagaku Ryoho. 2018 Dec;45(13):2435-2437.
7
[Remarkable improvement in a patient with metastatic and locally advanced HER2-positive breast cancer treated with trastuzumab plus vinorelbine].
Gan To Kagaku Ryoho. 2012 Mar;39(3):445-9.
8
Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.姑息性化疗:它只是提供虚假希望吗?姑息治疗在一名新诊断为转移性腺癌的年轻患者中的作用。
J Adv Pract Oncol. 2017 May-Jun;8(4):382-386. Epub 2017 May 1.
9
Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.HER2阳性转移性乳腺癌女性的当前及新出现的治疗方法
J Adv Pract Oncol. 2017 Mar;8(2):164-168. Epub 2017 Mar 1.
10
Chemotherapy de-escalation using an F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.基于 F-FDG-PET 的病理缓解适应性策略进行化疗降阶梯治疗 HER2 阳性早期乳腺癌患者(PHERGain):一项多中心、随机、开放标签、非对照、Ⅱ期临床试验。
Lancet Oncol. 2021 Jun;22(6):858-871. doi: 10.1016/S1470-2045(21)00122-4. Epub 2021 May 18.

引用本文的文献

1
Comparative survival analysis of HER2-positive Pregnancy-Associated Breast Cancer (PABC) and non-Pregnancy-Associated breast Cancer (non-PABC) cohorts: a matched control study.人表皮生长因子受体2(HER2)阳性妊娠相关乳腺癌(PABC)与非妊娠相关乳腺癌(non-PABC)队列的生存比较分析:一项匹配对照研究。
BMC Cancer. 2025 Aug 1;25(1):1252. doi: 10.1186/s12885-025-14602-1.
2
Coping strategies mediate the relationship between fear of cancer recurrence and quality of life in postoperative patients with prostate cancer: a multicentre survey.应对策略中介了前列腺癌术后患者恐惧癌症复发与生活质量之间的关系:一项多中心调查。
BMC Urol. 2024 Mar 1;24(1):49. doi: 10.1186/s12894-024-01428-5.
3

本文引用的文献

1
Analysis of a breast cancer mathematical model by a new method to find an optimal protocol for HER2-positive cancer.通过一种新方法分析乳腺癌数学模型,以找到针对 HER2 阳性癌症的最佳方案。
Biosystems. 2020 Nov;197:104191. doi: 10.1016/j.biosystems.2020.104191. Epub 2020 Aug 10.
2
Prognosis of pregnancy-associated breast cancer: a meta-analysis.妊娠相关性乳腺癌的预后:一项荟萃分析。
BMC Cancer. 2020 Aug 10;20(1):746. doi: 10.1186/s12885-020-07248-8.
3
Breast Cancer during Pregnancy-Current Paradigms, Paths to Explore.妊娠期乳腺癌——当前范式及探索路径
First Reported Case of Successful Conception and Delivery During Stage IV Breast Cancer Treatment: A Case Report and Literature Review.
首例IV期乳腺癌治疗期间成功受孕并分娩的病例报告:病例报告及文献综述
Cureus. 2023 Oct 17;15(10):e47201. doi: 10.7759/cureus.47201. eCollection 2023 Oct.
Cancers (Basel). 2019 Oct 28;11(11):1669. doi: 10.3390/cancers11111669.
4
Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer.韩国乳腺癌患者妊娠的预后影响。
Oncologist. 2019 Dec;24(12):e1268-e1276. doi: 10.1634/theoncologist.2019-0167. Epub 2019 Jul 2.
5
Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer.诊断并治疗过HER2阳性乳腺癌的年轻女性的妊娠情况。
Oncotarget. 2019 Jan 25;10(8):803-804. doi: 10.18632/oncotarget.26611.
6
Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy.转移性黑色素瘤患者接受双重检查点免疫治疗后实现活产。
Semin Oncol. 2018 Jun;45(3):164-169. doi: 10.1053/j.seminoncol.2018.03.003. Epub 2018 Mar 22.
7
Breast Cancer During Pregnancy.妊娠期乳腺癌
Cureus. 2018 Jul 8;10(7):e2941. doi: 10.7759/cureus.2941.
8
Propensity score to evaluate prognosis in pregnancy-associated breast cancer: Analysis from a French cancer network.采用倾向性评分评估妊娠相关性乳腺癌的预后:来自法国癌症网络的分析。
Breast. 2018 Aug;40:10-15. doi: 10.1016/j.breast.2018.03.014. Epub 2018 Apr 14.
9
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study.妊娠期间诊断的早期乳腺癌 5 年总生存率:一项回顾性病例对照多中心法国研究。
Eur J Cancer. 2018 May;95:30-37. doi: 10.1016/j.ejca.2018.02.030. Epub 2018 Apr 3.
10
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.妊娠期乳腺癌的生物学特性、分期及治疗:重新评估证据
Cancer Biol Med. 2018 Feb;15(1):6-13. doi: 10.20892/j.issn.2095-3941.2017.0146.